All Stories

  1. Niraparib in ovarian cancer: results to date and clinical potential

    Article • Therapeutic Advances in Medical Oncology, July 2017, SAGE Publications

    Dr Anselmo Papa

  2. Triple-negative breast cancer: new perspectives for targeted therapies

    Article • OncoTargets and Therapy, January 2015, Taylor & Francis

    Dr Federica Tomao, Dr Anselmo Papa

  3. Angiogenesis and antiangiogenic agents in cervical cancer

    Article • OncoTargets and Therapy, December 2014, Taylor & Francis

    Dr Federica Tomao, Dr Anselmo Papa

  4. Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

    Article • Therapeutics and Clinical Risk Management, November 2013, Taylor & Francis

    Dr Federica Tomao, Dr Edoardo Francini, Dr Anselmo Papa

  5. Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)

    Article • Cancer Management and Research, November 2013, Taylor & Francis

    Dr Davide Caruso, Dr Anselmo Papa

  6. Current status of bevacizumab in advanced ovarian cancer

    Article • OncoTargets and Therapy, July 2013, Taylor & Francis

    Dr Federica Tomao, Dr Davide Caruso, Dr Anselmo Papa

  7. Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer

    Article • OncoTargets and Therapy, September 2012, Taylor & Francis

    Dr Federica Tomao, Dr Angelo Zullo, Dr Anselmo Papa